[1]
Kumar, S. 2026. Redefining operability after neoadjuvant therapy in pancreatic ductal adenocarcinoma: a biology-driven surgical framework. International Surgery Journal. 13, 11 (Oct. 2026), 2386–2393. DOI:https://doi.org/10.18203/2349-2902.isj20263882.